Lupin, the pharma major has launched its generic version of morphine sulfate ER tablets that are used for management of severe pain.
The company has said that it the morphine sulfate ER Tablets has been launched by it in strengths of 15 mg, 30 mg, 60 mg, 100 mg and 200 mg having received an approval from the US Food and Drug Administration (USFDA).
Lupin has said in a statement that “It’s morphine sulfate ER tablets 15 mg, 30 mg, 60 mg, 100 mg and 200 mg are the AB rated generic equivalent of Purdue Pharma’s MS Contin ER Tablets 15 mg, 30 mg, 60 mg, 100 mg and 200 mg.”